The lungs stand at the crossroads of every breath and every bloodstream, making respiratory pathology a high-stakes discipline where architectural disruption, inflammatory cascades, and systemic ripple effects converge. You'll master how to recognize disease patterns through cellular and structural clues, systematically narrow differential diagnoses, and deploy evidence-based treatments that account for the lung's intimate dialogue with other organ systems. This lesson transforms you from observer to diagnostic detective, building the clinical precision needed when every breath counts.
Respiratory pathology encompasses the systematic study of lung diseases affecting 300 million alveoli, each measuring 0.2-0.3 mm in diameter. The respiratory system processes 12,000-15,000 liters of air daily, making it uniquely vulnerable to airborne pathogens, environmental toxins, and systemic inflammatory processes. Understanding pathological patterns requires mastering normal architecture first-from the conducting airways (generations 0-16) to the respiratory zone (generations 17-23).
📌 Remember: RAPID for major pathological categories - Restrictive diseases, Airway obstruction, Pleural disorders, Infections, Diffuse alveolar damage
The lung's dual blood supply creates unique pathological vulnerabilities. Pulmonary circulation (low pressure, 25/8 mmHg) handles gas exchange, while bronchial circulation (systemic pressure, 120/80 mmHg) supplies airways and pleura. This arrangement explains why pulmonary edema typically affects alveoli first, while bronchial artery bleeding causes massive hemoptysis.
⭐ Clinical Pearl: 95% of lung cancers arise from bronchial epithelium supplied by bronchial circulation, explaining why early tumors rarely cause gas exchange abnormalities
Cellular defense mechanisms operate at multiple levels. Alveolar macrophages clear 90% of inhaled particles >0.5 μm, while mucociliary escalator removes particles from conducting airways at 1-2 cm/minute. When these defenses fail, pathological processes follow predictable patterns based on particle size, toxicity, and host response.
| Pathological Category | Primary Location | Key Cells Involved | Typical Timeline | Reversibility | Mortality Risk |
|---|---|---|---|---|---|
| Acute Pneumonia | Alveolar spaces | Neutrophils, macrophages | 1-7 days | High (>90%) | 5-15% |
| Interstitial Fibrosis | Alveolar walls | Fibroblasts, type II pneumocytes | Months-years | Low (<20%) | 30-50% |
| Airway Obstruction | Bronchi/bronchioles | Eosinophils, smooth muscle | Minutes-hours | Moderate (60-80%) | 2-5% |
| Pleural Disease | Pleural space | Mesothelial cells | Days-weeks | Variable | 10-40% |
| Vascular Disease | Pulmonary vessels | Endothelial cells | Minutes-days | Moderate | 15-30% |
Acute Inflammatory Response
Chronic Inflammatory Patterns
Understanding respiratory pathology transforms clinical reasoning from symptom-based guessing to mechanism-based diagnosis, where tissue patterns predict disease progression and treatment response.
Loading diagram…
📌 Remember: DAMP-TLR sequence - Damage signals, Activate TLRs, Mobilize neutrophils, Produce cytokines, Trigger resolution, Limit damage, Repair tissue
Complement cascade activation occurs within 30-60 seconds of tissue injury. C3a and C5a fragments increase vascular permeability by 200-300%, while C5a attracts neutrophils with 10-fold greater potency than other chemotactic factors. Membrane attack complex (C5b-9) formation causes direct cellular damage in 15-30 minutes.
Early Phase Response (0-4 hours)
Intermediate Phase (4-24 hours)
⭐ Clinical Pearl: Neutrophil-to-lymphocyte ratio >10 predicts severe inflammatory response with 85% sensitivity for ARDS development
| Inflammatory Mediator | Peak Time | Primary Effect | Clinical Marker | Therapeutic Target | Normal vs Disease |
|---|---|---|---|---|---|
| Histamine | 5-15 min | Vasodilation | Flushing, hypotension | H1/H2 blockers | <1 vs 10-50 ng/mL |
| TNF-α | 6-12 hours | Endothelial activation | Fever, shock | Anti-TNF agents | <5 vs 50-500 pg/mL |
| IL-6 | 12-24 hours | Acute phase response | CRP elevation | Tocilizumab | <7 vs 100-1000 pg/mL |
| IL-10 | 24-48 hours | Anti-inflammatory | Resolution marker | Supportive | <10 vs 50-200 pg/mL |
| TGF-β | 3-7 days | Fibroblast activation | Fibrosis risk | Pirfenidone | <25 vs 100-500 pg/mL |
💡 Master This: Early intervention window exists in first 4-6 hours before neutrophil tissue damage becomes irreversible-explaining why corticosteroids work in early ARDS but fail after 24-48 hours
Resolution pathways activate through specialized pro-resolving mediators (SPMs). Lipoxin A4 production begins at 24-48 hours, promoting neutrophil apoptosis and macrophage efferocytosis. Resolvin E1 peaks at 72-96 hours, switching macrophages from M1 (pro-inflammatory) to M2 (anti-inflammatory) phenotype.
Understanding inflammatory timing enables precise therapeutic intervention, where anti-inflammatory agents work early, pro-resolution therapies work late, and antifibrotic agents prevent chronic complications.
Histological pattern recognition follows systematic architectural analysis. Alveolar patterns show airspace filling, interstitial patterns affect alveolar walls, and bronchiolar patterns involve small airways. Each pattern predicts specific disease categories with 80-95% accuracy when combined with clinical context.
📌 Remember: HAIL for CT patterns - Honeycombing (end-stage fibrosis), Air trapping (obstruction), Infiltrates (infection/inflammation), Lines (early fibrosis)
Alveolar Filling Patterns
Interstitial Thickening Patterns
Loading diagram…
Radiological-pathological correlation requires understanding tissue density relationships. Ground-glass opacity represents partial alveolar filling or minimal interstitial thickening, while consolidation indicates complete alveolar filling. Reticular patterns suggest interstitial fibrosis with >2mm septal thickening.
| CT Pattern | Histological Correlate | Disease Association | Reversibility | Prognosis | Treatment Response |
|---|---|---|---|---|---|
| Ground-glass | Partial alveolar filling | Early inflammation | High (>80%) | Good | Excellent |
| Consolidation | Complete alveolar filling | Pneumonia, edema | Moderate (60%) | Variable | Good |
| Honeycombing | End-stage fibrosis | UIP, advanced ILD | None (0%) | Poor | Minimal |
| Tree-in-bud | Bronchiolar inflammation | Infection, aspiration | High (>90%) | Good | Excellent |
| Mosaic attenuation | Air trapping | Small airway disease | Moderate (50%) | Variable | Moderate |
Temporal evolution patterns provide diagnostic clues. Acute processes (<4 weeks) show ground-glass or consolidation, subacute processes (4-12 weeks) develop reticular patterns, and chronic processes (>12 weeks) progress to honeycombing or traction bronchiectasis.
Infection Patterns
Inflammatory Patterns
💡 Master This: Pattern + distribution + timeline = diagnosis. Peripheral + lower lobe + chronic suggests UIP, while central + upper lobe + subacute indicates hypersensitivity pneumonitis
Understanding pattern recognition transforms radiological interpretation from descriptive reporting to predictive diagnosis, enabling early intervention before irreversible changes develop.
Systematic discrimination begins with anatomical localization. Upper lobe diseases include silicosis, hypersensitivity pneumonitis, and Langerhans cell histiocytosis. Lower lobe diseases encompass usual interstitial pneumonia, asbestosis, and drug-induced pneumonitis. Bilateral involvement suggests systemic processes, while unilateral patterns indicate localized pathology.
📌 Remember: UPPER for upper lobe diseases - Usual suspects (silicosis), Pneumoconiosis, Post-radiation, Eosinophilic granuloma, Respiratory bronchiolitis
Loading diagram…
Cavitary lesion discrimination requires understanding wall thickness and surrounding changes. Thin-walled cavities (<4mm) suggest infectious causes, while thick-walled cavities (>4mm) indicate malignancy or necrotizing infection. Multiple cavities point to septic emboli, Wegener's granulomatosis, or metastatic disease.
| Cavitary Pattern | Wall Thickness | Number | Location | Associated Findings | Most Likely Cause |
|---|---|---|---|---|---|
| Thin-walled | <4mm | Single | Any lobe | Air-fluid level | Lung abscess |
| Thick-walled | >4mm | Single | Upper lobe | Spiculated margins | Squamous cell CA |
| Multiple thin | <4mm | >3 lesions | Bilateral | Feeding vessel sign | Septic emboli |
| Multiple thick | >4mm | >3 lesions | Random | Nodular pattern | Metastases |
| Irregular | Variable | 1-3 lesions | Upper lobe | Saddle nose, sinusitis | Wegener's |
Interstitial pattern discrimination focuses on distribution and associated features. Usual interstitial pneumonia shows subpleural and basilar predominance with honeycombing. Nonspecific interstitial pneumonia demonstrates symmetric involvement without temporal heterogeneity. Hypersensitivity pneumonitis exhibits upper lobe predominance with centrilobular nodules.
💡 Master This: Distribution + timeline + steroid response discriminates fibrotic patterns. UIP = subpleural + chronic + steroid-resistant, NSIP = bilateral + subacute + steroid-responsive
Understanding systematic discrimination enables rapid differential narrowing, where pattern recognition combined with clinical context yields >90% diagnostic accuracy before invasive procedures.
Evidence-based treatment algorithms integrate severity assessment, pathophysiological mechanisms, and therapeutic targets. ARDS management follows lung-protective ventilation with tidal volumes 6 mL/kg, PEEP titration based on FiO2 requirements, and prone positioning for PaO2/FiO2 <150.
Loading diagram…
📌 Remember: ARDS-Net protocol - ARDS recognition, Respiratory rate <35, Driving pressure <15, Sedation minimized, Neuromuscular blockade if severe, ECMO if refractory, Tidal volume 6 mL/kg
Pharmacological interventions target specific pathophysiological mechanisms. Corticosteroids reduce inflammation when given early (<72 hours), neuromuscular blockade improves ventilator synchrony in severe cases, and inhaled nitric oxide provides selective pulmonary vasodilation.
| Intervention | Indication | Dosing | Duration | Monitoring | Success Rate |
|---|---|---|---|---|---|
| Methylprednisolone | Early ARDS | 1-2 mg/kg/day | 7-14 days | Glucose, infection | 60-70% |
| Cisatracurium | Severe ARDS | 15 mg/hour | 48 hours max | TOF monitoring | 75-85% |
| Inhaled NO | Severe hypoxemia | 5-20 ppm | <7 days | MetHb levels | 50-60% |
| ECMO | Refractory ARDS | Flow 3-5 L/min | Weeks | ACT, hemolysis | 40-60% |
| Prone positioning | P/F <150 | >12 hours/day | Until improvement | Pressure sores | 70-80% |
Infection management follows antimicrobial stewardship principles. Community-acquired pneumonia treatment uses severity scores (CURB-65, PSI) to guide antibiotic selection and hospitalization decisions. Healthcare-associated pneumonia requires broad-spectrum coverage with de-escalation based on culture results.
💡 Master This: Severity assessment drives treatment intensity-CURB-65 ≥2 requires hospitalization, ≥3 suggests ICU consideration, and ≥4 predicts >25% mortality without aggressive intervention
Understanding evidence-based algorithms transforms treatment from empirical guessing to precision medicine, where biomarker-guided therapy and severity-stratified protocols optimize outcomes while minimizing adverse effects.
Cardiopulmonary integration demonstrates bidirectional pathophysiology. Pulmonary vascular disease increases right ventricular afterload, leading to cor pulmonale in >60% of patients with severe COPD. Left heart failure causes pulmonary venous hypertension, resulting in interstitial edema and secondary pulmonary hypertension.
📌 Remember: HEART-LUNG connections - Hypertension (pulmonary), Edema (cardiogenic), Arrhythmias (hypoxia), Right failure (cor pulmonale), Thromboembolism, Left failure (backward), Unloading (preload), Neurohormonal activation, Gas exchange impairment
Immunological integration reveals how systemic autoimmune diseases target pulmonary tissues. Rheumatoid arthritis causes interstitial pneumonia in 10-20% of patients, systemic sclerosis leads to pulmonary fibrosis in >70%, and ANCA-associated vasculitis produces pulmonary hemorrhage in 45-60%.
Loading diagram…
| CTD | ILD Prevalence | Typical Pattern | Antibody Association | Treatment Response | Prognosis |
|---|---|---|---|---|---|
| Systemic Sclerosis | 70-80% | NSIP | Anti-Scl-70 | Moderate | Variable |
| Rheumatoid Arthritis | 10-20% | UIP | Anti-CCP | Poor | Poor |
| Polymyositis/DM | 30-50% | NSIP/OP | Anti-Jo-1 | Good | Good |
| Sjögren's | 10-20% | LIP | Anti-Ro/La | Moderate | Good |
| SLE | 5-10% | AIP | Anti-RNP | Good | Good |
Metabolic integration connects respiratory failure with systemic metabolic derangements. Chronic hypercapnia causes renal bicarbonate retention, chronic hypoxemia triggers erythropoietin production, and respiratory acidosis affects drug metabolism and electrolyte balance.
💡 Master This: Respiratory-systemic crosstalk means lung disease affects every organ system-hypoxemia impairs cognitive function, hypercapnia causes somnolence, and chronic inflammation accelerates cardiovascular disease
Understanding multi-system integration transforms respiratory medicine from organ-specific treatment to comprehensive care, where systemic manifestations guide therapeutic priorities and comorbidity management determines overall outcomes.
Essential Diagnostic Thresholds form the foundation of rapid clinical decision-making. ARDS severity stratifies by PaO2/FiO2 ratios: mild >200, moderate 100-200, severe <100. Pulmonary embolism probability increases with Wells score >4, D-dimer >500 ng/mL, and right heart strain on echocardiography.
📌 Remember: CRITICAL-5 thresholds - CO2 retention >50 mmHg, Respiratory rate >30, Infiltrates bilateral, Tidal volume <6 mL/kg, Inspiratory pressure >30, Compliance <40, Acidosis pH <7.25, Lactate >4 mmol/L
| Clinical Scenario | Key Threshold | Immediate Action | Time Frame | Success Marker | Failure Backup |
|---|---|---|---|---|---|
| Severe ARDS | P/F ratio <100 | Prone positioning | <6 hours | P/F improvement >20% | ECMO consultation |
| Massive PE | RV/LV >1.5 | Thrombolysis | <90 minutes | Hemodynamic stability | Embolectomy |
| Tension PTX | Tracheal deviation | Needle decompression | <5 minutes | Breath sounds return | Chest tube |
| Status asthmaticus | Peak flow <25% | High-dose β-agonists | <30 minutes | Peak flow >50% | Intubation |
| Acute exacerbation | pH <7.25 | NIV + steroids | <2 hours | pH >7.30 | Intubation |
Pattern Recognition Shortcuts enable instant diagnosis. Bilateral infiltrates + normal heart size + acute onset = ARDS. Unilateral infiltrate + fever + productive cough = pneumonia. Peripheral infiltrates + eosinophilia + migratory pattern = organizing pneumonia.
Therapeutic Decision Trees streamline treatment selection. Inflammatory markers guide steroid timing: CRP >100 mg/L suggests bacterial infection (avoid steroids), CRP 20-50 mg/L with lymphocytosis indicates viral or inflammatory process (consider steroids).
Loading diagram…
💡 Master This: Time-sensitive interventions save lives-early recognition + rapid implementation + continuous monitoring = optimal outcomes. Delayed treatment exponentially increases mortality risk in respiratory emergencies
Understanding rapid diagnostic precision transforms emergency respiratory care from reactive management to proactive intervention, where pattern recognition and threshold-based decisions enable life-saving treatment within critical time windows.
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more
1. A 28-year-old woman having limited cutaneous scleroderma for the last 10 years complains of shortness of breath for the last one month. Pulmonary function tests (PFT) are as follows. What is the most likely diagnosis in this case?
Answer: B. Pulmonary hypertension
Pulmonary hypertension is most likely because longstanding limited cutaneous systemic sclerosis with DLCO 50% predicted and preserved spirometry and TLC suggests pulmonary vascular disease, although PFTs alone do not confirm it. Pulmonary bronchiectasis often causes airflow obstruction but can have normal spirometry; an isolated diffusion defect is less characteristic. Congestive heart failure can reduce DLCO with normal or restricted volumes, but this clinical context more strongly favors pulmonary vascular disease. Interstitial lung disease may initially reduce DLCO before restriction develops, so normal TLC does not exclude early disease; the isolated diffusion defect in longstanding limited cutaneous systemic sclerosis nevertheless favors pulmonary hypertension.
2. Which feature is NOT associated with chronic granulomatous disease?
Answer: C. Autosomal dominant inheritance
Autosomal dominant inheritance is the exception: CGD is classically X-linked recessive or autosomal recessive. Defective intracellular oxidative killing is characteristic because NADPH oxidase activity is impaired, although microbial ingestion is preserved. Recurrent staphylococcal infections occur because Staphylococcus aureus is a characteristic catalase-positive pathogen in CGD. An abnormal nitroblue tetrazolium test reflects impaired oxidative burst and is a traditional screening finding, although dihydrorhodamine flow cytometry is now preferred.
3. A 60-year-old man presents with progressive exertional dyspnea. HRCT shows basal and subpleural-predominant reticulation, traction bronchiectasis, and clustered honeycomb cysts, with heterogeneous involvement. There is no predominant ground-glass opacity, consolidation, nodularity, significant air trapping, or hilar lymphadenopathy. ANA is weakly positive at 1:80, but there are no clinical features of connective-tissue disease. Which diagnosis best describes the HRCT pattern?
Answer: C. Usual interstitial pneumonia
Usual interstitial pneumonia - The basal, subpleural-predominant honeycombing with traction bronchiectasis and heterogeneous fibrosis meets the standard HRCT description of a UIP pattern. Isolated low-titre ANA positivity does not establish CTD-associated ILD or favor NSIP over a characteristic UIP pattern. This identifies UIP morphology, not necessarily idiopathic pulmonary fibrosis; the latter additionally requires exclusion of identifiable causes. Nonspecific interstitial pneumonia - NSIP usually shows predominant ground-glass opacity and fine reticulation, often with relative subpleural sparing; substantial honeycombing is uncommon but possible. Cryptogenic organizing pneumonia - COP typically shows patchy peripheral or peribronchovascular consolidation rather than this fibrotic pattern. Pulmonary sarcoidosis - Fibrotic sarcoidosis can produce honeycombing, but usually has upper/perihilar-predominant fibrosis and associated nodal or perilymphatic abnormalities rather than the basal subpleural pattern described.
4. A 35-year-old woman with a long history of dyspnea, chronic cough, sputum production, and wheezing dies of respiratory failure following a bout of lobar pneumonia. She had never smoked. Which of the following underlying conditions is most likely associated with the pathologic changes shown in the lung autopsy?
Answer: D. Alpha-1 antitrypsin deficiency
Alpha-1 antitrypsin deficiency is the best answer because the image shows emphysema in a young lifelong nonsmoker. Deficient antiprotease activity permits elastase-mediated alveolar destruction; this disorder characteristically causes panacinar emphysema, although the supplied image does not establish lobar distribution. Cystic fibrosis predominantly causes mucus plugging, recurrent infection and bronchiectasis. Anti-glomerular basement membrane disease causes pulmonary haemorrhage, often with glomerulonephritis, rather than emphysema. Primary ciliary dyskinesia causes impaired mucociliary clearance and bronchiectasis rather than the emphysematous destruction shown.
5. What is the probable diagnosis in the patient with the provided flow volume loop (FVL)?
Answer: B. Fixed upper airway obstruction
Fixed upper airway obstruction - Flattening of both the inspiratory and expiratory limbs produces a characteristic box-shaped flow-volume loop, indicating fixed upper airway obstruction. - A lesion such as tracheal stenosis causes fixed anatomical narrowing that limits maximal airflow regardless of respiratory effort. Lower airway obstructive disease - Obstructive airway disease typically produces a scooped-out, concave expiratory limb from dynamic airway collapse, rather than flattening of both limbs. - It is associated with reduced peak expiratory flow and a prolonged expiratory phase, contrasting with the loop’s fixed plateau pattern. Restrictive ventilatory defect - Restrictive airway disease generally preserves the normal flow-volume loop contour while reducing FVC and TLC, rather than creating plateaus. - The curve appears smaller with reduced volumes but maintains its shape, unlike the flattened inspiratory and expiratory limbs shown here. Variable extrathoracic obstruction - Variable extrathoracic obstruction predominantly flattens the inspiratory limb, whereas the supplied loop shows flattening of both limbs.
6. Chemotaxis is mediated by-
Answer: D. Leukotriene B4 and C5a
Leukotriene B4 and C5a - Leukotriene B4 and C5a are potent chemoattractants that direct neutrophils and other leukocytes toward sites of inflammation. - These mediators amplify the acute inflammatory response by promoting leukocyte recruitment, making them appropriate mediators of chemotaxis. Histamine and serotonin - Histamine and serotonin mainly mediate vascular responses rather than the potent directed leukocyte migration associated with LTB4 and C5a Bradykinin and prostaglandin E2 - Bradykinin and prostaglandin E2 chiefly contribute to pain and vascular responses rather than serving as the classic potent chemoattractants tested here Leukotriene C4 and C3a - Leukotriene C4 primarily causes bronchoconstriction, while C3a participates in complement-mediated inflammation but is less potent in chemotaxis than C5a. - These mediators have different principal functions and lack the strong leukocyte-attracting activity characteristic of LTB4 and C5a.
7. Which of the following is NOT a typical clinical feature of bronchiectasis?
Answer: D. Night sweats
Night sweats is not a typical clinical feature of bronchiectasis, although it may occur with associated infection; prominent night sweats should prompt evaluation for another or additional cause. Chest pain - Chest pain can occur in bronchiectasis because persistent coughing causes musculoskeletal strain and associated inflammation may irritate the pleura. - Although not a defining symptom, chest pain may accompany infective exacerbations or inflammation extending toward the pleural tissues. Productive cough - A chronic productive cough containing substantial purulent sputum is the hallmark clinical symptom of bronchiectasis. - This results from impaired mucociliary clearance, persistent infection, and accumulation of secretions within dilated, damaged airways. Hemoptysis - Hemoptysis is a common clinical feature of bronchiectasis caused by inflammation and structural damage involving the bronchial walls and vessels. - Fragile bronchial blood vessels may rupture, producing blood-streaked sputum or, in severe cases, massive pulmonary haemorrhage.
8. Which of the following is NOT a standard management option for established fat embolism syndrome?
Answer: C. Surgical intervention
Surgical intervention is not a standard treatment for established fat embolism syndrome, which is primarily managed with supportive care. Surgery may stabilize the initial long-bone fracture and help prevent further embolization, but it does not directly treat established fat embolism syndrome. Supplemental oxygen treats hypoxemia. Hemodynamic support maintains circulation when instability is present. Mechanical ventilation supports patients with severe respiratory failure.
9. Which of the following is NOT a typical differential diagnosis for a solitary pulmonary nodule?
Answer: B. Mycetoma
Mycetoma - In this thoracic context, mycetoma denotes an intracavitary fungal ball, usually an aspergilloma; it should not be confused with subcutaneous mycetoma, which may be fungal or bacterial. - When involving the lung, it usually forms a fungus ball (aspergilloma) within a pre-existing cavity, so it is not a typical differential for a solitary pulmonary nodule. Lung cancer - Lung cancer is a primary malignant lung tumor and an important consideration when evaluating a solitary pulmonary nodule. - Its inclusion is appropriate because early detection of lung malignancy affects prognosis and treatment, particularly for adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Hamartoma - Hamartoma is a benign tumor-like malformation composed of disorganized normal tissues, including cartilage, fat, and muscle. - It is among the most common benign causes of a solitary pulmonary nodule and therefore belongs in the differential diagnosis. Tuberculoma - A tuberculoma is a granuloma caused by Mycobacterium tuberculosis and may appear as a well-defined solitary pulmonary nodule or mass. - It represents a contained form of pulmonary tuberculosis and is an important differential, especially in tuberculosis-endemic areas.
10. An adult with symptomatic pulmonary sarcoidosis requires initial systemic therapy and has no glucocorticoid contraindication. Which drug is first-line?
Answer: D. Prednisolone
Prednisolone is the first-line systemic drug for symptomatic pulmonary sarcoidosis requiring treatment when glucocorticoids are suitable. Methotrexate is generally a steroid-sparing alternative rather than the initial choice in this setting. Azathioprine is another steroid-sparing immunosuppressant and is not the routine initial treatment here. Infliximab is generally reserved for refractory disease rather than initial systemic treatment.
1. In ARDS, activation of _____ by proinflammatory cytokines induces _____ and _____-mediated damage of _____ pneumocytes
neutrophils · free radical · protease · both type I and II
2. _____ results in _____ emphysema that is most severe in the _____ lobes of the lung
1-antitrypsin deficiency · panacinar · lower
3. Most pneumoconiosis involves the _____ lobes of the lung (coal worker's pneumoconiosis (CWP), silicosis, berylliosis), except _____
upper · asbestosis
4. In acute respiratory distress syndrome (ARDS), tissue injury is caused mainly by .
neutrophils::Immune cell
5. _____ pneumonia is characterized by diffuse, patchy inflammation that is localized to _____ areas at alveolar walls
Atypical · interstitial
6. _____ is characterized by macrophages laden with _____, causing inflammation and fibrosis
Coal workers' pneumoconiosis · carbon
7. Histopathology showing the _____ effect are suggestive of a _____ carcinoma of the lung.
Azzopardi · small cell
8. _____ bodies are seen in cryptogenic organizing pneumonia.
Masson
9. The diagnosis is _____ carcinoma of the lung.
large cell
10. Asbestos bodies contain _____ and thus may be visualized using a _____ stain
iron · Prussian blue
Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.
Scan to download app
Enter your email to get your 75% OFF code and unlock the full Indian Medical PG question bank on the app.